Company Profile: Viatris
Viatris is a new kind of global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life by expanding access to medicines regardless of geography or circumstance; advancing responsible, sustainable operations and targeted innovation to improve patient health; and leveraging its collective expertise to connect more people to more products and services. Viatris has scientific, manufacturing and distribution expertise with proven regulatory, medical and global commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris Australia is one of the leading suppliers of medicines to the Pharmaceutical Benefits Scheme, currently with 43 out of the top 50 PBS products distributed by volume being a Viatris medicine. Their broad portfolio ranges from iconic brands, generic, complex generic and branded medicines, biosimilars and over-the-counter products across more than 10 major therapeutic areas. In November, Viatris will be celebrating their second anniversary, following the combination of Mylan and Pfizer’s Upjohn business. In Australia the manufacturing facility at Carole Park has been operational for 40 years – growing from 6 employees to over 600. Viatris is a global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The company has local offices in both Australia and New Zealand. In 2021, Viatris sold more than 80 billion doses of medicine worldwide and reached approximately 90% of low- and lower-middle-income countries with approximately 7.7 billion doses of medicine. In Australia the world class manufacturing facility at Carole Park, Queensland, exports medicine to more than 40 countries. Viatris produces approximately 3 billion doses of medicine every year in approximately 450 different formulations and with the opening of the new manufacturing suite, this will increase to approximately 4 billion doses of medicine every year. Sylvain Vigneault, Country Manager (pictured), believes that Viatris is in a really […]